about
Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptorRegulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicityFluoride increases superoxide production and impairs the respiratory chain in ROS 17/2.8 osteoblastic cells.Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells.Effect of glucagon-like peptide 2 on hepatic, renal, and intestinal disposition of 1-chloro-2,4-dinitrobenzeneAntiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole.The trypanocidal benznidazole promotes adaptive response to oxidative injury: Involvement of the nuclear factor-erythroid 2-related factor-2 (Nrf2) and multidrug resistance associated protein 2 (MRP2).Physiological and pathophysiological factors affecting the expression and activity of the drug transporter MRP2 in intestine. Impact on its function as membrane barrier.Modulation of expression and activity of intestinal multidrug resistance-associated protein 2 by xenobiotics.Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis.Modulation of biotransformation systems and ABC transporters by benznidazole in rats.Coordinated induction of GST and MRP2 by cAMP in Caco-2 cells: Role of protein kinase A signaling pathway and toxicological relevance.Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.Induction of intestinal multidrug resistance-associated protein 2 by glucagon-like Peptide 2 in the rat.Induction of intestinal multidrug resistance-associated protein 2 (Mrp2) by spironolactone in rats.Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats.The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.Acute regulation of multidrug resistance-associated protein 2 localization and activity by cAMP and estradiol-17β-D-glucuronide in rat intestine and Caco-2 cells.Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma.Estrogen receptor-α mediates human multidrug resistance associated protein 3 induction by 17α-ethynylestradiol. Role of activator protein-1.Intestinal multidrug resistance-associated protein 2 is down-regulated in fructose-fed rats.Biphasic modulation of cAMP levels by the contraceptive nomegestrol acetate. Impact on P-glycoprotein expression and activity in hepatic cells.The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma.The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.Inhibition of multidrug resistance-associated protein 2 (MRP2) activity by the contraceptive nomegestrol acetate in HepG2 and Caco-2 cells
P50
Q28484352-121D1317-4C39-4269-A03F-6ACED14445CEQ28544454-613BD13A-FD07-4908-8763-8F91B0C9C13DQ33806999-E79F4F3A-CBC6-4FDA-AEC4-9BA6DABB8F33Q34175189-DBB286B6-4715-4C8B-8C16-AD82671FD526Q36057404-E0529C4A-54C1-48DB-90EB-A190E27AC095Q37692463-1A277673-4E68-4ED3-A563-DA8E8DA764BDQ38736649-00ADAB0F-63E1-4E3E-BC2F-E7200DF33D88Q38770841-6F2B788D-8C40-4048-A828-028B0A8EBAAEQ38816227-0AB9E82E-24C4-416D-9CFE-8CE155568D2EQ38828188-3E5C5E9F-B8BB-4A29-A83E-734700E00C31Q39182548-E9C09E4E-15F3-4723-92E3-78DE829A6587Q40430904-FC925E20-4A7F-496D-A12F-E14BF6D2BA75Q42110098-840B33C0-8998-4CA9-8BA5-DFAD43F14263Q42701577-9EB31715-AE9F-4C0E-92E7-246AF3C80135Q42706165-A001D8B5-0A3E-4120-9305-ED9A9D2AB7ADQ42933674-8FE83E1D-8A8C-4219-86AC-5926563EDC26Q43274321-10523B3E-B1F5-448F-8530-082C97EE5995Q43931477-130BF19D-5615-4673-8A96-899A5A15BD5DQ47442621-0F47F247-62AA-406A-9D87-5840713E7FB8Q47625097-4D0B092E-5C50-4E3E-BE78-90C7C4D1EF15Q50888361-0A6A1CD4-D1FE-47DE-A1AD-EA4E81C1E38EQ50926590-AAEFB53E-467B-4FB8-AA6D-F1EDD407C0CAQ51286888-99638E6C-7C92-44CD-9A53-A0BC08480425Q52569825-76575944-0B91-4222-A79C-F237930E532EQ52731004-981FD5EA-D89D-4DFA-A915-89FE9948955DQ53132656-B4290F44-8C94-4583-BA48-5A08A8211FDCQ89454768-069FCF64-50FC-4AC2-8900-6267B6D26D65
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Juan Pablo Rigalli
@ast
Juan Pablo Rigalli
@en
Juan Pablo Rigalli
@es
Juan Pablo Rigalli
@nl
Juan Pablo Rigalli
@sl
type
label
Juan Pablo Rigalli
@ast
Juan Pablo Rigalli
@en
Juan Pablo Rigalli
@es
Juan Pablo Rigalli
@nl
Juan Pablo Rigalli
@sl
prefLabel
Juan Pablo Rigalli
@ast
Juan Pablo Rigalli
@en
Juan Pablo Rigalli
@es
Juan Pablo Rigalli
@nl
Juan Pablo Rigalli
@sl
P108
P106
P1153
35741495500
P21
P214
4153061218919200435
P31
P3946
P496
0000-0003-4168-9396